MeOhr Ventures is an early-stage venture capital firm focused on catalyzing world changing cures for globally significant, high-mortality diseases. MeOhr will deploy its investment resources into a high conviction, concentrated portfolio of early stage biotech opportunities. The vehicle will operate with a single objective: curing disease. Opportunities will be sourced from ultra-high potential life-science inventors and researchers.